302 related articles for article (PubMed ID: 28902406)
1. Genetic and epigenetic insights into uveal melanoma.
Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of microRNAs and their implications in uveal melanoma.
Yang C; Wang Y; Hardy P
Cell Mol Life Sci; 2021 Jan; 78(2):545-559. PubMed ID: 32783068
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
[TBL] [Abstract][Full Text] [Related]
4. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
6. Role of epigenetic deregulation in hematogenous dissemination of malignant uveal melanoma.
Smolkova B; Horvathova Kajabova V; Zmetakova I; Kalinkova L; Czanner G; Markova A; Furdova A
Neoplasma; 2018 Nov; 65(6):840-854. PubMed ID: 30334454
[TBL] [Abstract][Full Text] [Related]
7. P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.
Pan H; Ni H; Zhang L; Xing Y; Fan J; Li P; Li T; Jia R; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Oct; 37(10):13533-13543. PubMed ID: 27468714
[TBL] [Abstract][Full Text] [Related]
8. Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.
Herwig-Carl MC; Sharma A; Höller T; Holz FG; Schlitter AM; Loeffler KU
Exp Eye Res; 2019 May; 182():175-181. PubMed ID: 30954503
[TBL] [Abstract][Full Text] [Related]
9. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
10. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
11. Spliceosome Mutations in Uveal Melanoma.
Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of son of sevenless homolog 1 is predictive of poor prognosis in uveal malignant melanoma patients.
Wang YS; Wu L
Ophthalmic Genet; 2019 Feb; 40(1):22-28. PubMed ID: 30714452
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of deregulated microRNAs in uveal melanomas.
Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
[TBL] [Abstract][Full Text] [Related]
15. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
[TBL] [Abstract][Full Text] [Related]
16. Integrated analyses identify potential prognostic markers for uveal melanoma.
Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
[TBL] [Abstract][Full Text] [Related]
17. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
[TBL] [Abstract][Full Text] [Related]
18. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
20. The genetic evolution of metastatic uveal melanoma.
Shain AH; Bagger MM; Yu R; Chang D; Liu S; Vemula S; Weier JF; Wadt K; Heegaard S; Bastian BC; Kiilgaard JF
Nat Genet; 2019 Jul; 51(7):1123-1130. PubMed ID: 31253977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]